Journal Article

The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms

Song, Guangchun, Newman, Scott, Schwartz, Jason R., Westover, Tamara, Liu, Yanling, Pounds, Stanley, Ma, Xiaotu, Gruber, Tanja, Rubnitz, Jeffrey E., Easton, John, Zhang, Jinghui, Montefiori, Lindsey, Wu, Gang, Maciaszek, Jamie L., Wu, Huiyun, Mullighan, Charles G., Chen, Xiaolong, Branstetter, Cristyn, Kumar, Priyadarshini, Brady, Samuel W., Ma, Jing, Hiltenbrand, Ryan, Kamens, Jennifer, Klco, Jeffery M., Walsh, Michael P., Robert Michael, J., Nichols, Kim E., Walsh, Michael F.

2021

Overview

Pediatric therapy-related myeloid neoplasms (tMN) occur in children after exposure to cytotoxic therapy and have a dismal prognosis. The somatic and germline genomic alterations that drive these myeloid neoplasms in children and how they arise have yet to be comprehensively described. We use whole exome, whole genome, and/or RNA sequencing to characterize the genomic profile of 84 pediatric tMN cases (tMDS: n  = 28, tAML: n  = 56). Our data show that Ras/MAPK pathway mutations, alterations in RUNX1 or TP53 , and KMT2A rearrangements are frequent somatic drivers, and we identify cases with aberrant MECOM expression secondary to enhancer hijacking. Unlike adults with tMN, we find no evidence of pre-existing minor tMN clones (including those with TP53 mutations), but rather the majority of cases are unrelated clones arising as a consequence of cytotoxic therapy. These studies also uncover rare cases of lineage switch disease rather than true secondary neoplasms. Paediatric therapy-related myeloid neoplasms (tMN) have a dismal prognosis and have not been comprehensively profiled. Here the authors characterise the molecular landscape of 84 paediatric tMN patients, and find that, unlike adult tMNs, these do not emerge from pre-existing clones and that MECOM dysregulation is frequent.

• Publisher: Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
• Subject: 45/22 / 45/23 / 45/88 / 45/90 / 45/91 / 631/208/199 / 631/67/1990/1673 / 631/67/1990/283/1897 / 631/67/69 / Child / Children / Cloning / Cytotoxicity / Exome Sequencing / Gene Expression Regulation, Neoplastic / Gene sequencing / Genomes / Genomics / Histone-Lysine N-Methyltransferase / Humanities and Social Sciences / Humans / Leukemia, Myeloid, Acute - genetics / Leukemia, Myeloid, Acute - therapy / MAP kinase / multidisciplinary / Mutation / Myelodysplastic Syndromes / Myeloid-Lymphoid Leukemia Protein / Neoplasms / Neoplasms, Second Primary - genetics / Neoplasms, Second Primary - therapy / Pediatrics / Prognosis / Ribonucleic acid / RNA / Runx1 protein / Science / Science (multidisciplinary) / Therapy / Tumors